AvertD Post-Approval Study

Recruiting now

Conditions studied: Opioid Use Disorder

In brief

A Prospective Post-Approval Study of AvertD to Evaluate Device Performance, Prescribing Impact, and Labeling Comprehension in the Intended Use Population

Key facts

Study ID

NCT07135323

Run by

Prescient Medicine Holdings, Inc.

People needed

4000

Starts

2024-11-15

Expected to finish

2031-11-01

Last updated by the study team

2025-08-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• ≥18 years of age
• Prior to first opioid prescription
• Being considered for first oral opioid prescription (4-30 days)
• Prescribed AvertD as part of care
• Willing and able to complete yearly assessments for 5 years
• Signed informed consent

You may not qualify if…

• Planned opioid prescription <4 or >30 days
• Any condition making participation unsafe or infeasible per investigator judgment

Where it is running

• Concentrics Research — Indianapolis, Indiana, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.